Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-06-05
1999-07-13
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4353201, 435459, A61K 4800, C12N 1500, C12N 1587
Patent
active
059226854
ABSTRACT:
In an approach to genetic therapy for treating tumors, a genetic construction encoding the p35 and p40 subunits of the cytokine IL-12 is delivered into cells of individuals in need of therapy so as to express IL-12 in cells and to cause regression of established tumors.
REFERENCES:
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5015580 (1991-05-01), Christou et al.
patent: 5149655 (1992-09-01), McCabe et al.
Vieweg et al (1995) Clinical Invest. 13, 193-201.
Vieweg et al. (1994) Cancer Res. 54, 1760-1765.
Xu et al. (1997) Vaccine 12, 1534-1536.
Gubler et al., "Coexpression of Two Distinct Genes is Required to Generate Secreted Bioactive Cytotoxic Lymphocyte Maturation Factor," Proc. Natl. Acad. Sci. USA 88:4143-4147 (1991).
Lotze et al., "Gene Therapy of Cancer-Immunological Approaches," J. Cellular Biochemistry S17E: p. 184 (1993).
Lotze, Michael T., "Cytokine Gene Therapy of Cancer-IL-4 and IL-12 Regulate the Immune Response," Cancer Gene Therapy (Conference Abstracts) 1:(2) 147-148 (1994).
Martinotti et al., "CD4 T Cells Inhibit In Vivo the CD8-Mediated Immune Response Against Murine Colon Carcinoma Cells Transduced with Interleukin-12 Genes," Eur. J. Immunol. 25:137-146 (1995).
Robbins et al., "Gene Therapy for Cancer and Arthritis," Cancer Gene Therapy (Conference Abstracts) 1(2):p.147 (1994).
Tahara et al., "Fibroblasts Genetically Engineered to Secrete Interleukin 12 Can Suppress Tumor Growth and Induce Antitumor Immunity to a Murine Melanoma in Vivo," Cancer Research 54:182-189 (1994).
Rakhmilevich Alexander L.
Yang Ning-Sun
Crouch Deborah
McCracken Thomas P.
PowderJect Vaccines, Inc.
LandOfFree
IL-12 gene therapy of tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-12 gene therapy of tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-12 gene therapy of tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2275731